Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dried plasma is a biological blood product derived from human donor plasma that has been freeze-dried or spray-dried to allow for long-term storage at ambient temperatures. It is primarily used in emergency and prehospital settings for the treatment of massive hemorrhage and hemorrhagic shock. Upon reconstitution with sterile water, it provides essential coagulation factors to the patient, helping to prevent or treat trauma-induced coagulopathy and improve survival outcomes. The Västra Götaland Region is currently evaluating its efficacy in a Phase 4 clinical trial (NCT07012863) comparing it to standard crystalloid care in ambulance settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dried plasma (Velico).